发现抗体/抗IP3受体-2(ITPR2)抗体/0.2 ml/ACC-116-0.2 ml

价格
¥9500.00
货号:ACC-116-0.2ml
浏览量:127
品牌:Discovery
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat#:ACC-116
AlternativeNameInositol1,4,5-trisphosphatereceptortype2,IP3R2,InsP3R2,IP3receptorisoform2
  • LyophilizedPowder
  • AntigenIncl.
  • Type:Polyclonal
    Host:Rabbit
    Reactivity:r
    Mayalsoworkin:h*,m*
      • Peptide(C)RLGFLGSNTPHENH,correspondingtoaminoacidresidues2683-2696ofratIP3R2(Accession P29995). Intracellular,C-terminus.
        Anti-IP3 Receptor-2 (ITPR2) Antibody
    Accession(Uniprot)NumberP29995
    GeneID81678
    PeptideconfirmationConfirmedbyaminoacidanalysisandmassspectrometry.
    HomologyMouse,human-13/14aminoacidresiduesidentical.
    RRIDAB_2340910.
    PurityAffinitypurifiedonimmobilizedantigen.
    FormLyophilizedpowder.Reconstitutedantibodycontainsphosphatebufferedsaline(PBS),pH7.4,1%BSA,0.05%NaN3.
    IsotypeRabbitIgG.
    StoragebeforereconstitutionTheantibodyshipsasalyophilizedpowderatroomtemperature.Uponarrival,itshouldbestoredat-20°C.
    Reconstitution25µl,50µlor0.2mldoubledistilledwater(DDW),dependingonthesamplesize.
    Antibodyconcentrationafterreconstitution0.8mg/ml.
    StorageafterreconstitutionThereconstitutedsolutioncanbestoredat4°Cforupto1week.Forlongerperiods,smallaliquotsshouldbestoredat-20°C.Avoidmultiplefreezingandthawing.Centrifugeallantibodypreparationsbeforeuse(10000xg5min).
    NegativecontrolantigenstoragebeforereconstitutionLyophilizedpowdercanbestoredintactatroomtemperaturefor2weeks.Forlongerperiods,itshouldbestoredat-20°C.
    Negativecontrolantigenreconstitution100µldoubledistilledwater(DDW).
    Negativecontrolantigenstorageafterreconstitution-20°C.
    PreadsorptionControl1µgpeptideper1µgantibody.
    StandardqualitycontrolofeachlotWesternblotanalysis.
    Applications:if,ih,wb
    Mayalsoworkin:ic*,ifc*,ip*
      • Anti-IP3 Receptor-2 (ITPR2) Antibody
        Westernblotanalysisofratbrainmembrane(lanes1and3)andratbasophilicleukemia(RBL)celllinelysate(lanes2and4):
        1,2. Anti-IP3 Receptor-2 (ITPR2) Antibody(#ACC-116),(1:200).
        3,4.Anti-IP3 Receptor-2(ITPR2)Antibody,preincubatedwiththenegativecontrolantigen.
      • Anti-IP3 Receptor-2 (ITPR2) Antibody
        ExpressionofIP3R2inratspinalcord
        ImmunohistochemicalstainingofIP3R2inratspinalcordsectionsusing Anti-IP3 Receptor-2(ITPR2)Antibody(#ACC-116). A.IP3R2immunoreactivity(red)appearsinneuronalsoma(horizontalarrows)andprocesses(verticalarrows).B.NuclearstainingusingDAPIasthecounterstain(blue).C.MergedimageofAandB.
    References
    • 1.Furuichi,T.etal.(1989)Nature342,32.
    • 2.Berridge,M.J.etal.(2003)Nat.Rev.Mol.CellBiol.4,517.
    • 3.Furuichi,T.etal.(1994)Curr.Opin.Neurobiol.4,294.
    • 4.Varnai,P.etal.(2005)Proc.Natl.Acad.Sci.U.S.A.102,7859.
    • 5.Fujino,I.etal.(1995)CellTissueRes.280,201.
    • 6.Yaroslavskiy,B.B.etal.(2007)J.CellSci.120,2884.
      • Inositol1,4,5-trisphosphatereceptors(IP3R)areintracellularCa2+ releasechannelslocatedontheendoplasmicreticulum(ER)andmediateCa2+ mobilizationfromtheERtothecytoplasminresponsetothebindingofthesecondmessenger,inositol1,4,5-trisphosphate(IP3)1.IP3-inducedCa2+ releaseistriggeredbyvariousexternalstimuli,andmostnon-excitablecellsusethismechanismastheprimaryCa2+ signalingpathway.IP3Rsarethereforethoughttohaveimportantphysiologicalrolesinvariouscelltypesandtissues2.

        ThreesubtypesofIP3Rs,derivedfromthreedistinctgenes,havebeenidentifiedinmammals3.AllthreereceptorshavesixtransmembranedomainsandaporeregionbetweenTM5andTM6.TheN-terminusaswellastheC-terminusarecytoplasmic.EachIP3RconsistsofanN-terminalligandbindingdomain(LBD)andaC-terminaldomainwhichislinkedbyalongregulatorydomain.TheC-terminusisconstitutivelyactive,suggestingthattheregulatorydomainisrequiredtomaintainthesuppressionofchannelactivity4

        Type2IP3R(IP3R2)isexpressedinvarioustissuesandcelllines.IP3R2mRNAislocalizedintheintralobularductcellsofthesuBMAndibulargland,theurinarytubulecellsofthekidney,theepithelialcellsofepididymalductsandthefolliculargranulosacellsoftheovary5.IP3R2isactiveduringosteoclastdifferentiation,anditsabsencecausesapartialdefectinosteoclasticdifferentiation.

    Applicationkey:

    CBE-Cell-basedELISA,FC-Flowcytometry,ICC-Immunocytochemistry,IE-IndirectELISA,IF-Immunofluorescence,IFC-Indirectflowcytometry,IHC-Immunohistochemistry,IP-Immunoprecipitation,LCI-Livecellimaging,N-Neutralization,WB-Westernblot

    Speciesreactivitykey:

    H-Human,M-Mouse,R-Rat
    receivea25µlfreetrialsample!
    Lastupdate:10/11/2019

    Anti-IP3Receptor-2(ITPR2)Antibody(#ACC-116)isahighlyspecificantibodydirectedagainstanepitopeoftheratprotein.Theantibody canbeusedinwesternblotandimmunohistochemistryapplications.IthasbeendesignedtorecognizeIP3R2fromrat,mouseandhumansamples.

    Forresearchpurposesonly,notforhumanuse
    Discovery®抗体是Cambridge Research Biochemicals的目录抗体业务。 CRB是全球第二大最古老的肽公司,也是抗体研究市场的先驱,目前正以Discovery®Antibodies的名义建立一系列新验证的靶标抗体。 Discovery®抗体将专注于研究用抗体(早期药物“发现”),并将补充我们非常成功且长期存在的定制抗体业务(www.crbdiscovery.com)。我们已经以新颖,复杂,稀有和翻译后修饰的特异性抗体而闻名,这些受追捧的靶标将出现在我们的Discovery®Antibody目录范围内。  我们于2017年2月,在发现肽之后一年,并且在詹姆斯·库克船长(他当时最伟大的探险家)于1776年从英国出发,乘坐“ HMS发现”号开始租用新水域和“发现全球各地的新土地。因此,“发现”这个名称似乎适合东北制造商–詹姆斯·库克的故乡。 在1700年代后期对全球新发现土地的追求与医学研究的新“发现”以及2000年人类基因组图谱的发现之间,还有其他相似之处。  有关更多详细信息,请参见有关Discovery®抗体发布的新闻稿。   Cambridge Research Biochemicals  (www.crbdiscovery.com)成立于1980年,是英国领先的定制肽和抗体工具的独立生产商,为全球制药,生命科学和学术领域的研究人员提供产品。其产品的主要应用是定制的实验室规模试剂,用于早期药物发现中的主要研究证据,并支持临床研究中的生物标志物计划。该公司生产各种口味的肽,从简单到修饰,稳定和放射性标记,再到从毫克到克到最高纯度的染料标记。此外,CRB是产生高度特异性和靶向抗体(多克隆抗体和单克隆抗体)的公认专家。荧光染料标记也是重点。自1994年以来,该公司于2016年启动了其首个目录业务DISCOVERY®。
    • 资质认证

      获得国家资质,权威认证!

    • 全国联保

      全国联保,官方无忧售后

    • 正规发票

      正规发票,放心购买

    • 签订合同

      签订合同,保障您的权益

    /**/